This website uses cookies to improve your experience. Read our Privacy Policy
Research articles, tutorials, and practical guidance tagged Molecular Docking.
Find a method, workflow, scientific concept, or software decision.
Filter the publication by research area or keyword.
Evidence-led articles on scientific methods, reproducible workflows, and software decisions.
Decide which waters, metals, ions, and cofactors belong in a docking receptor by biological role, structural evidence, ligand mechanism, force-field compatibility, and controlled validation.
Compare local, cloud, and hybrid molecular docking by real workload, data boundaries, runtime continuity, reproducibility, collaboration, governance, and total cost - not by deployment label alone.
A practical AutoDock Vina reporting checklist for preserving prepared inputs, software versions, search-box geometry, parameters, seeds, raw poses, failures, and the evidence needed to re-execute a docking study.
Choose a receptor by target state, local pocket evidence, ligand context, and validation. Compare when a holo, apo, AlphaFold, or receptor ensemble best fits a reproducible protein-small-molecule docking campaign.
A docking screen ends with a ranked list, but an assay needs a defensible shortlist. Learn how to combine rank, pose quality, chemical diversity, artifact risk, availability, and controls before experimental testing.
Modern in silico drug discovery is not one algorithm. Learn how target evidence, structure prediction, molecular docking, virtual screening, AI, physics-based refinement, and experiments work as one traceable decision system.
Screen multiple ligands without losing the scientific record. Preserve stable identities, one frozen Vina protocol, failures, ranked poses, exports, and local job history across the batch.
An SDF file can load and still be unfit for docking. Diagnose valence, aromaticity, fragments, stereochemistry, hydrogens, 3D geometry, minimization, and PDBQT failures before AutoDock Vina.
Validate a molecular docking workflow before committing a ligand library: separate pose recovery from screening discrimination, test early enrichment and robustness, and define a defensible go/no-go decision.